Company profileSME (from the award notice)

Norgine GmbH

Legal form: GmbH
Seat: Wettenberg, Germany

Based on the notices and sources Inteliwert covers; not a complete record. Last checked 29 September 2026.

Identifiers

As the covered sources state them.

Register entry: HRB 9522

Track record in public tenders

Awards in the covered notices over the last 36 months, per CPV division.

Based on the notices and sources Inteliwert covers; not a complete record.

Awards per CPV division, last 36 months. Based on the notices and sources Inteliwert covers; not a complete record.
CPV division	Awards	Award value (excl. VAT)	Buyers	Repeat buyers	First award	Last award
33 Medical equipments, pharmaceuticals and personal care products	1	€1	1	0	29 September 2026	29 September 2026

Awards

Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V und §130 c SGB V zu den Präparaten mit den Wirkstoffen Mavorixafor (Xolremdi) und Eisenmaltol (Feraccru)Buyer: GWQ ServicePlus AG · Award value: €1 excl. VAT · Awarded: 29 September 2026 · CPV 33600000
Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8, 130c Abs. 1 SGB V zwischen der IKK classic und der Norgine GmbH zu Xolremdi (R)Buyer: IKK classic · Award value: €1 excl. VAT · Awarded: 13 July 2026 · CPV 33600000

Certifications and prequalification

No certification or prequalification found in the covered sources.

A certification missing here is unknown, not absent.

Website and LinkedIn

Not found in the indexed notices.

Open tenders that might fit

Possible match based on public information

Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.

OpenTenderSME (from the award notice)

Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Buyer
Techniker Krankenkasse
Place
DE600 (Hamburg)
Deadline
31 Aug 2028, 23:58 (UTC+02:00)

Reasons
- Won a contract in CPV group 336 (2026-09-29) Evidence · checked 10 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 10 Nov 2026
- 2 awards in this field in 36 months, from 2 buyers Evidence · checked 10 Nov 2026
Last checked 10 Nov 2026, 17:31 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)

Open house Arzneimittelrabattverträge zum Wirkstoff Pridinol, ATC M03BX03

Buyer
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Place
DEB3D (Rheinland-Pfalz)
Deadline
30 Jun 2028, 23:59 (UTC+02:00)

Reasons
- Won a contract in CPV group 336 (2026-09-29) Evidence · checked 10 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 10 Nov 2026
- 2 awards in this field in 36 months, from 2 buyers Evidence · checked 10 Nov 2026
Last checked 10 Nov 2026, 09:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)

Open house Arzneimittelrabattverträge zum Wirkstoff Natriumoxybat, ATC N07XX04

Buyer
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Place
DEB3D (Rheinland-Pfalz)
Deadline
30 Jun 2028, 23:59 (UTC+02:00)

Reasons
- Won a contract in CPV group 336 (2026-09-29) Evidence · checked 10 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 10 Nov 2026
- 2 awards in this field in 36 months, from 2 buyers Evidence · checked 10 Nov 2026
Last checked 10 Nov 2026, 09:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tacrolimus, ATC L04AD02 für die Zeit 01.09.2026 - 31.08.2028

Buyer
DAK-Gesundheit
Deadline
5 Jul 2028, 12:00 (UTC+02:00)
Published value
€1 excl. VAT

Reasons
- Won a contract in CPV group 336 (2026-09-29) Evidence · checked 10 Nov 2026
- The contract value is close to the values of its past awards Evidence · checked 10 Nov 2026
- 2 awards in this field in 36 months, from 2 buyers Evidence · checked 10 Nov 2026
Last checked 10 Nov 2026, 10:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Natalizumab (ausschließlich Darreichungsform ILO), ATC L04AA23 für die Zeit 01.09.2026 - 31.08.2028

Buyer
DAK-Gesundheit
Deadline
5 Jul 2028, 12:00 (UTC+02:00)
Published value
€1 excl. VAT

Reasons
- Won a contract in CPV group 336 (2026-09-29) Evidence · checked 10 Nov 2026
- The contract value is close to the values of its past awards Evidence · checked 10 Nov 2026
- 2 awards in this field in 36 months, from 2 buyers Evidence · checked 10 Nov 2026
Last checked 10 Nov 2026, 10:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Emtricitabin + Rilpivirin + Tenofovir disoproxil fumarat, ATC J05AR08 für die Zeit 01.09.2026 - 31.08.2028

Buyer
DAK-Gesundheit
Deadline
5 Jul 2028, 12:00 (UTC+02:00)
Published value
€1 excl. VAT

Reasons
- Won a contract in CPV group 336 (2026-09-29) Evidence · checked 10 Nov 2026
- The contract value is close to the values of its past awards Evidence · checked 10 Nov 2026
- 2 awards in this field in 36 months, from 2 buyers Evidence · checked 10 Nov 2026
Last checked 10 Nov 2026, 10:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)

Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Buyer
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
Place
DED21 (Sachsen)
Deadline
30 Sept 2027, 23:58 (UTC+02:00)

Reasons
- Won a contract in CPV group 336 (2026-09-29) Evidence · checked 10 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 10 Nov 2026
- 2 awards in this field in 36 months, from 2 buyers Evidence · checked 10 Nov 2026
Last checked 10 Nov 2026, 16:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)

Arzneimittel-Rabattverträge ab 01.09.2026 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens

Buyer
AOK NordWest
Place
DEA53 (Nordrhein-Westfalen)
Deadline
1 Jul 2028, 17:00 (UTC+02:00)

Reasons
- Won a contract in CPV group 336 (2026-09-29) Evidence · checked 10 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 10 Nov 2026
- 2 awards in this field in 36 months, from 2 buyers Evidence · checked 10 Nov 2026
Last checked 10 Nov 2026, 19:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)

Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Buyer
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
Place
DED21 (Sachsen)
Deadline
31 Aug 2028, 23:58 (UTC+02:00)

Reasons
- Won a contract in CPV group 336 (2026-09-29) Evidence · checked 10 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 10 Nov 2026
- 2 awards in this field in 36 months, from 2 buyers Evidence · checked 10 Nov 2026
Last checked 10 Nov 2026, 16:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)

Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Buyer
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
Place
DED21 (Sachsen)
Deadline
31 Aug 2028, 23:58 (UTC+02:00)

Reasons
- Won a contract in CPV group 336 (2026-09-29) Evidence · checked 10 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 10 Nov 2026
- 2 awards in this field in 36 months, from 2 buyers Evidence · checked 10 Nov 2026
Last checked 10 Nov 2026, 16:30 (UTC+01:00)Official notice

Is this your company?

Send corrections, or ask us to remove the profile, to hello@inteliwert.com. You can also ask that the company never be tagged on LinkedIn.

About this profile

Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.

Based on the notices and sources Inteliwert covers; not a complete record.

Last checked 29 September 2026.

Markdown version